NFKB1 and chronic obstructive pulmonary disease: Since inflammation is the leading cause of COPD, and the TLR4/NF-kB signaling pathway mediates pulmonary inflammation, we used COPD model rats to explore the anti-inflammatory mechanisms of Feikang Granules.